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knee extension strength
Abstract
BACKGROUND: Hand-held dynamometry is a portable and inexpensive method to quantify muscle
strength. To determine if muscle strength has changed, an examiner must know what part of the
difference between a patient's pre-treatment and post-treatment measurements is attributable to real
change, and what part is due to measurement error. This study aimed to determine the relative and
absolute reliability of intra and inter-observer strength measurements with a hand-held dynamometer
(HHD). METHODS: Two observers performed maximum voluntary peak torque measurements
(MVPT) for isometric knee extension in 24 patients with haematological malignancies. For each patient,
the measurements were carried out on the same day. The main outcome measures were the intraclass
correlation coefficient (ICC +/- 95%CI), the standard error of measurement (SEM), the smallest
detectable difference (SDD), the relative values as % of the grand mean of the SEM and SDD, and the
limits of agreement for the intra- and inter-observer ;3 repetition average; and the ;highest value of 3
MVPT; knee extension strength measures. RESULTS: The intra-observer ICCs were 0.94 for the
average of 3 MVPT (95%CI: 0.86-0.97) and 0.86 for the highest value of 3 MVPT (95%CI: 0.71-0.94).
The ICCs for the inter-observer measurements were 0.89 for the average of 3 MVPT (95%CI:
0.75-0.95) and 0.77 for the highest value of 3 MVPT (95%CI: 0.54-0.90). The SEMs for the
intra-observer measurements were 6.22 Nm (3.98% of the grand mean (GM) and 9.83 Nm (5.88% of
GM). For the inter-observer measurements, the SEMs were 9.65 Nm (6.65% of GM) and 11.41 Nm
(6.73% of GM). The SDDs for the generated parameters varied from 17.23 Nm (11.04% of GM) to
27.26 Nm (17.09% of GM) for intra-observer measurements, and 26.76 Nm (16.77% of GM) to 31.62
Nm (18.66% of GM) for inter-observer measurements, with similar results for the limits of agreement.
CONCLUSION: The results indicate that there is acceptable relative reliability for evaluating knee
strength with a HHD, while the measurement error observed was modest. The HHD may be useful in
detecting changes in knee extension strength at the individual patient level.
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Abstract
Background: Hand-held dynamometry is a portable and inexpensive method to quantify muscle strength. To
determine if muscle strength has changed, an examiner must know what part of the difference between a patient's
pre-treatment and post-treatment measurements is attributable to real change, and what part is due to
measurement error. This study aimed to determine the relative and absolute reliability of intra and inter-observer
strength measurements with a hand-held dynamometer (HHD).
Methods: Two observers performed maximum voluntary peak torque measurements (MVPT) for isometric knee
extension in 24 patients with haematological malignancies. For each patient, the measurements were carried out
on the same day. The main outcome measures were the intraclass correlation coefficient (ICC ± 95%CI), the
standard error of measurement (SEM), the smallest detectable difference (SDD), the relative values as % of the
grand mean of the SEM and SDD, and the limits of agreement for the intra- and inter-observer '3 repetition
average' and the 'highest value of 3 MVPT' knee extension strength measures.
Results: The intra-observer ICCs were 0.94 for the average of 3 MVPT (95%CI: 0.86–0.97) and 0.86 for the
highest value of 3 MVPT (95%CI: 0.71–0.94). The ICCs for the inter-observer measurements were 0.89 for the
average of 3 MVPT (95%CI: 0.75–0.95) and 0.77 for the highest value of 3 MVPT (95%CI: 0.54–0.90). The SEMs
for the intra-observer measurements were 6.22 Nm (3.98% of the grand mean (GM) and 9.83 Nm (5.88% of GM).
For the inter-observer measurements, the SEMs were 9.65 Nm (6.65% of GM) and 11.41 Nm (6.73% of GM). The
SDDs for the generated parameters varied from 17.23 Nm (11.04% of GM) to 27.26 Nm (17.09% of GM) for
intra-observer measurements, and 26.76 Nm (16.77% of GM) to 31.62 Nm (18.66% of GM) for inter-observer
measurements, with similar results for the limits of agreement.
Conclusion: The results indicate that there is acceptable relative reliability for evaluating knee strength with a
HHD, while the measurement error observed was modest. The HHD may be useful in detecting changes in knee
extension strength at the individual patient level.
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Intensive medical treatment regimens can significantly
improve survival in patients with haematological malig-
nancies [1-3]. The cancer therapy itself, including chemo-
therapy or radiotherapy, damages healthy cells
throughout the body, resulting in side-effects including
nausea, emesis, decreased nutritional intake and anaemia.
Higher fatigue levels that are associated with decreased
levels of activity and lengthened bed rest contribute to
muscular catabolism and atrophy [4]. As a result, func-
tional limitations and muscle weakness may persist even
well beyond the period of active treatment [5-7].
Patients with haematological malignancies may benefit
from physical exercise programs in terms of maintenance
or even improvement in physical activity levels [7], fitness
levels [8,9], and muscular strength [5,10,11]. Assessment
of muscle strength is an important part of the manage-
ment of cancer patients, particularly in determining the
response to a muscular strength training program [12-14].
It is thus important to be able to accurately quantify the
muscle strength of patients who are recovering from
intensive medical treatment.
Muscular strength can be assessed both in research set-
tings and in clinical practice settings by means of isoki-
netic and hand-held dynamometers (HHD). One of the
advantages of using isokinetic dynamometers in patients
with chronic diseases is the ability to assess muscle
strength dynamically through a range of movements at
various velocities, which may more accurately reflect func-
tional performance [15,16]. However, isokinetic strength
testing protocols may be too time consuming in typical
clinical settings, and the size of the equipment can also be
problematic (i.e., lack of portability). Clinically, HHD
represents a simple, portable and relatively inexpensive
alternative to isokinetic machines for assessing muscle
strength [16]. Moreover, hand-held dynamometers pro-
vide quantification of muscle strength, and are more sen-
sitive to change in muscle strength than simple manual
muscle tests [16,17].
Evidence of the validity of HHD has been provided in sev-
eral studies, including a comparison of HHD with isoki-
netic strength measurements to assess lower limb strength
in the elderly (r = 0.91) [18], a comparison of HHD and
manual muscle testing (r = 0.77) [17], and of HHD and
the Timed-Up-and-Go-test (r = 0.64 to -0.94). [19] Nollet
et al. also provided evidence for the validity of a HHD in
lower strength ranges in patients with post-polio syn-
drome [20].
To be clinically meaningful, however, the muscle strength
assessment procedure must be reliable enough to evaluate
outcomes of a therapeutic intervention [21]. Reliability
can be reported in relative or absolute terms [21]. Relative
reliability statistics indicate the degree of association
between 2 or more measures (e.g., intraclass correlation
coefficients or ICCs), [22] but they do not provide clinical
guidance for assessing real changes at an individual
patient level [23,24]. The relative reliability of hand-held
dynamometers for knee extension has been examined in
numerous populations. ICCs' of 0.75 or higher have been
reported in studies of healthy young and elderly adults
[25,26], community-dwelling elderly fallers [19,27], peo-
ple with acquired brain injury [28], elderly after hip frac-
ture and elective hip and knee arthroplasty [29,30], adults
with cerebral palsy [31], and patients with chronic
obstructive pulmonary disease (COPD) [16].
Absolute reliability reflects the magnitude of the differ-
ences between two measures [32]. Examples of these sta-
tistics are the standard error of measurement (SEM), the
corresponding 95% confidence interval, the smallest
detectable difference (SDD), and the limits of agreement
(LA). To be clinically useful, an assessment with an HHD
must have only a small amount of measurement error in
detecting real change over time.[33] A retest difference in
a patient with a value smaller than the SEM is likely to be
the result of 'measurement noise' and is unlikely to be
detected reliably in practice; a difference greater than the
SDD is likely to be a real difference with 95% certainty
[21]. The absolute reliability of HHD has been reported
by several authors [16,26,27,31,33,34]. However, meas-
ures of reliability are specific to the populations and test-
ing procedures used. This implies that the findings of
previous studies may not be applicable to patients with
haematological malignancies. Disease- and treatment-
related symptoms, including de-conditioning, muscle
weakness, and fatigue may affect not only the reliability,
but also the safety of performing HHD [16,22]. Therefore,
the investigation of the measurement error of an HHD in
patients with haematological malignancies is warranted.
In daily physiotherapy or rehabilitation practice, strength
measurements for the same patient are often performed
by several examiners. However, the measurement error
associated with the assessment of strength by one observer
(intra-observer reliability) may be different than that asso-
ciated with the assessment of strength by several observers
(inter-observer reliability)[35]. For this reason, it is
important to determine both the intra- and inter-observer
reliability of the measurements obtained with a HHD.
This study aimed to determine the relative and absolute
reliability (measurement error) of intra and inter-observer
strength measurements with a HHD in a sample of
patients with haematological malignancies.
Methods
Selection criteria
The study sample included patients with a diagnosis of
haematological cancer who had completed treatmentPage 2 of 11
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Oncology and Haematology of the University Hospital
Zurich. Patients were excluded if they were experiencing
the direct side-effects of high-dose chemotherapy (e.g.
fever, haemoglobin level < 10 g/dl, emesis, dyspnoea, ≤ 36
of 52 points on the Functional Assessment for Cancer
Therapy-Anemia (FACT-An) scale [36,37]), or had gait
abnormalities, known impairment of the lower limbs,
severe graft versus host disease (GVHD) except for grade I
not requiring treatment, painful joints, instable osteolyses
of the vertebrae, chronic low back pain, lesions of the cen-
tral or peripheral nervous system, uncontrolled cardiovas-
cular disease, thyroid disease, or diabetes.
Forty-nine patients were initially invited to participate in
the study. Five of these patients (10.2%) were subse-
quently excluded due to low haemoglobin values and/or
severe fatigue, 2 patients (4%) were excluded due to knee
pain at the time of measurement, and 12 patients (24%)
were not interested in participating. Of the remaining 30
patients, 14 had leukaemia treated with induction chem-
otherapy following peripheral blood stem-cell transplan-
tation, 11 non-Hodgkin lymphoma treated with high-
dose chemotherapy alone (n = 10) or high-dose chemo-
therapy following autologous stem cell transplantation (n
= 1) and 4 multiple myeloma/plasmacytoma treated with
high-dose chemotherapy alone (n = 1) or high-dose
chemotherapy following 2 cycles of autologous stem-cell
transplantation (n = 3). All participating patients were in
a physically stable condition and provided written
informed consent. The ethics committee of the Canton of
Zurich approved the study.
Descriptive measurements
Blood values (haemoglobin in g/dl) were determined at
the time of an outpatient visit to the hospital. Self-
reported fatigue was measured with the German-language
version of the FACT-An scale. [37] The FACT-An scale
includes 13 items relating to both the symptoms and con-
sequences of cancer fatigue, and is highly reliable [37].
Haemoglobin values and self-reported fatigue were
assessed because both of these variables (i.e. low haemo-
globin levels and high fatigue levels) can have adverse
effects on physical performance over time [38]. The
patient's height was assessed to the nearest 0.5 cm with a
wall fixed tape measure. Weight was assessed to the near-
est 0.5 kg with a weighting machine, SECA©, Model 791.
Isometric muscle strength assessment
The maximum voluntary push torque (MVPT) was
assessed with the CompuFet HHD. The CompuFet is a
portable force evaluation and testing system (weight 0.45
KG), designed by Hoggan Health Industries Inc. (USA).
The HHD sets a high or low threshold for the minimal
force with which to start. The high threshold recording of
the test data begins at 13.6 Newton. The display shows
peak force read-outs in 4.4 Newton increments. The Com-
puFet HHD has a test-range from 3.6 to 440 Newton [39].
Standardization of the measurement protocol
The MVPT for knee extension was tested at a knee angle of
25 degrees [33]. An angle of 25 degrees was selected to
correspond to the knee angle at which the force produc-
tion is of crucial importance in walking, as has been
shown in biomechanical analyses of this activity
[33,40,41]. Patients were positioned sitting upright, with
no back support, and with the hips in 90 degrees flexion.
The patient stabilized the trunk by grasping the table. The
thigh of the patient was stabilized by the examiner's hand.
Thus, the examiner assured that sufficient counterforce
was produced by the thigh, so that the lower limb could
not pivot down during the break test with the knee near
full extension. In this way, the examiner could ensure that
the knee extension was really "broken". The joint angles
were defined according to the Academy of Orthopaedic
Surgeons (AAOS) system [42]. The HHD was positioned
perpendicular to the tibia, at 80% of the shank length
(between the marks at the lower edge of the 'lateral epi-
condylus' and the lower edge of the 'lateral malleolus'),
distal to the knee. The knee joint centre and the 80%
shank length were marked with a dot on the patients' skin.
The position of the patient, the examiner, and the HHD
were standardized (Figure 1).
The test was performed as a 'break test'. The break tech-
nique requires the examiner to overpower a maximal
effort by the patient, thereby producing a measurement of
eccentric muscle strength [43]. The break technique pro-
duces higher values than the 'make technique'. The make
technique requires the patient to exert a maximal isomet-
ric contraction while the examiner holds the dynamome-
ter in a fixed position. Both the break and the make
method (ICCs for both methods are 0.90 or higher) pro-
duce strength measurements that have excellent reliabil-
ity, although the 'break' technique produces higher values
[44]. The patient's forced exertion was standardized
according to 'Caldwell', with a build-up phase of 2 sec-
onds, and steady maximal force exertion over 3 seconds,
after which the examiner breaks through the forced exer-
tion of the patient [33,45]. The patient was encouraged by
means of standardized, verbal instructions during the
tests. The break test requires sufficient force from the
examiner [46]. For this study, MVPT for isometric exten-
sion strength measurements was expressed in Newton-
meter (Nm). A concave interchangeable patch attachment
for curved surfaces [39] was used to avoid pain at the tibia
during the assessment. The average of 3 peak torque meas-
urements and the highest value of 3 peak torque measure-
ments were used as outcomes. The knee extension score
was estimated from the torque signal, multiplied by thePage 3 of 11
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knee joint.
Measurement procedure
The test procedure started with a familiarization session of
three knee extension repetitions of the dominant limb
[21], which was defined as the preferred limb for kicking.
The rest interval between the test repetitions was 30 sec-
onds. The reliability study started with one examiner
(intra-observer reliability) performing two measurement
sessions of three repetitions each. Subsequently, the sec-
ond examiner (inter-observer reliability) performed a
third measurement session of three repetitions. Thus, a
total of nine repetitions on the dominant limb were per-
formed by each patient. The measurement sessions,
including the training session, were separated by 60 min-
utes. After one hour, no real change in muscle strength in
patients is expected, so any observed differences were
expected to be due to measurement error. In addition, the
break-interval is long enough to avoid muscular fatigue
effects [33].
The reliability of the knee extension measurements was
evaluated at the Institute of Physical Medicine at the Uni-
versity Hospital Zurich by two examiners, both female
students (examiner 1: 80 Kg, 1.64 m, and examiner 2: 53
Kg, 1.62 m) from the Institute of Human Movement Sci-
ences and Sport of the ETH, Zurich. As neither examiner
had previous experience with manual muscle testing, they
underwent training sessions to learn the requisite manual
muscle testing skills. They practised the manual muscle
testing skills on fellow students, and on 3 patients with
haematological malignancies. The students practised the
muscle strength measurements during 8 sessions for 1.5
hours, totalling approximately 12 hours. During this
training they were supervised by a senior physical thera-
pist (RHK) with experience in manual muscle testing.
Statistical Analyses
Normality of the data was tested with the Kolmogorov-
Smirnov test [47]. A two-way mixed model (ICC3.1 and
ICC3.3) and a two-way random effect model (ICC2.1 and
ICC2.3) were used for the intra, and inter-observer reliabil-
ity estimation, respectively [48]. An ICC > 0.75 was
defined as acceptable reliability. The SEM was calculated
from the average known standard deviation (SD) and the
relative reliability coefficient (ICC) of the measurement
used for our sample: SEM = SD(√ 1-ICC) [49,50]. The cor-
responding 95% confidence interval (95%CI), in which
the true score (drawn from the normally distributed pop-
ulation) is expected to fall, was ± 1.96 × SEM [33,51,52].
The broader the limits of the 95% confidence interval, the
less confident the estimation of the true score and, as a
consequence, the less confident the detection of real
change due to intervention [50]. This knowledge about
the standard error of the measurement is necessary before
one can say that a change has occurred [50,53].
Moreover, when analyzing a difference between two con-
secutive observations, one must consider the standard
error of the observed score for both the first (SEM(first meas-
urement session)) and the second (SEM(second measurement session))
observations. The SDD is defined as the measure of statis-
tically significant change between two independently
obtained measurements. Given a probability value of α =
0.05 as indication for statistical significance, the SDD is
estimated as 1.96 × √(SEM(first strength assessment)2 + SEM(second
strength assessment)
2) [24]. Assuming that the standard error of
the measurement of the observed score of the first and sec-
ond observations are equal, the SDD is 1.96 × √2 × SEM.
For a statistically significant change between two separate
observations to be detected, this change must be at least
the SDD of the measurement procedure [49]. The SEM
and SDD's were expressed as absolute values and in rela-
tive values as % of the grand mean.
The limits of agreement (LA) were calculated as the differ-
ence against the mean plot (LA = mean + 1.96 × SD) as
proposed by Bland and Altman [54]. The Bland and Alt-
man plots graphically display between measurement dif-
ferences, thus allowing direct insight into the variability of
the measurement under study [55].
A repeated measures ANOVA was carried out to test for
learning effects within the three MVPT strength measure-
ments [56]. The differences between means of the intra-
observer and inter-observer measurements (p < 0.05)
Standardization of measurementsFigure 1
Standardization of measurements. Performance of a 
maximum voluntary peak torque assessment at a knee angle 
of 25° of flexion. Standard body position of the patient and 
the device are shown. The patient stabilized the trunk by 
grasping the table.Page 4 of 11
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graphic differences between patients included and
excluded from the study were calculated by means of a
Student's t-test [57]. All statistical analyses were per-
formed using SPSS® 15 for Windows (SPSS, Inc.).
Results
The HHD-assessments were tolerated by all 30 patients.
Of these 30 patients, 6 (1 woman and 5 men) were
excluded from the analyses because they did not perform
the knee extension measurements according to the stand-
ardized procedures and because they exceeded the torque
limit of 218 Nm. These 6 patients were significantly
younger, taller and heavier (p < 0.05), than the 24 patients
included in the analysis (Table 1).
For the remaining 24 patients, all results of the muscle
strength measurements and the difference in muscle
strength measurements between intra-session 1, intra-ses-
sion 2, and the inter-session were normally distributed.
The relative reliability of the HHD, including the ICCs
and the 95%CIs, was acceptable, ranging from 0.77 to
0.94, for the intra-observer and inter-observer measure-
ment sessions, respectively (Tables 2 and 3).
The absolute reliability of the SEM, the SDD, and the rel-
ative values as % of the grand mean of the SEM and SDD
are presented in Tables 2 and 3. The 95% limits of agree-
ment according to the method of Bland and Altman are
presented in Figures 2, 3, 4, 5. The ANOVA for repeated
measures yielded no significant changes (p > 0.05)
between the three MVPT strength measurements, indicat-
ing that there were no learning effects from the first to the
third measurements for the intra- and inter-tester observ-
ers. There were no significant differences in muscle
strength between the intra- and inter-observer sessions for
the average of 3 MVPT measurements (Tables 4 + 5) or for
the highest value of 3 MVPT measurements (Tables 6 + 7).
Discussion
This study evaluated the relative and absolute reliability of
a strength assessment protocol using an HHD among a
sample of haematological cancer patients recovering from
high-dose treatment. We used the ICC (with accompany-
ing 95%CI) to estimate relative reliability. Relative relia-
bility is highly dependent on the variability observed in
the patient sample, and relates to the ability to classify
patients' strength measurements in the same rank. Thus,
relative reliability is most relevant for assessing instru-
ments that are to be used for discriminative purposes [23].
Guyatt et al.[24] demonstrated that discriminative instru-
ments require a high level of relative reliability. That is,
the measurement error should be small in comparison to
the variability between the observers. In other words, if
the difference between the observers is large, a certain
amount of measurement error is acceptable [23,24].
However, if the aim is to measure change in health status,
which is often the case in clinical practice, absolute relia-
bility is more relevant [23,24]. Absolute reliability
describes the agreement between repeated measurements
and is concerned with measurement error [23,24]. For an
evaluative instrument, it is not the variability between the
observers that is of primary concern, but rather measure-
ment error [23,24]. The measurement error should be
smaller than the changes that the observer wishes to detect
[23,58]. We calculated the SEM, the SDD and the limits of
agreement to estimate absolute reliability.
Table 1: Descriptive characteristics
Demographic and medical 
measures
Patients with haematological malignancies 
(n = 24; Included for analyses)
Patients with haematological malignancies 
(n = 6; Excluded for analyses)
p-value
Mean Age in years (sd) 50.1
(14.6)
39.5
(8.9)
0.042
Mean Height in cm (sd) 170.1
(7.7)
183.5
(8.1)
0.001
Mean Weight in kg (sd) 72.2
(11.7)
87.5
(9.3)
0.007
Mean BMI in kg/m2 (sd) 24.8 (3.9) 26.1 (1.4) 0.359
Mean 80% shank-length in cm (sd) 32.3
(2.2)
36.3
(1.50)
0.000
Mean time (days) since medical 
treatment (sd)
149.0
(70.2)
148.7
(69.2)
0.991
FACT-An
(13 fatigue items)
(Sd)
40.5
(7.0)
37.5
(11.7)
0.426
Haemoglobin (g/dl)
(Sd)
12.4
(1.7)
12.9
(2.3)
0.545
Mean values for included and excluded patients with hematological malignancies. Differences were calculated by an unpaired t-test.Page 5 of 11
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follows: the intra-observation of the average of 3 MVPT
'knee strength' assessments provided acceptable relative
reliability (ICC3.3 = 0.94). The reliability of this parameter
is affected by the variance statistic of the assessments from
'intra session 1', which was 644.65 Nm (calculated as the
square of the standard deviation [25.39 Nm]), and the
assessment from intra session 2', which was 847.39 Nm
(sd 29.11 Nm) (see the distribution from Bland and Alt-
man in Figure 2). When taking the measurement error
into account, an SDD equal to or greater than 17.23 Nm
between two measurements should be used as the thresh-
old for a true clinical change in knee extension. The results
of the other examination models in this study: the Inter-
observer reliability for the average of 3 MVPT measure-
ments (ICC2.3), the intra-observer reliability for the high-
est value of 3 MVPT measurements (ICC3.1), and the inter-
observer reliability for the highest value of 3 MVPT meas-
urements (ICC2.1), should be interpreted in the same way
(see Tables 2 and 3, and Figures 3, 4, 5). Thus, when eval-
uating knee strength measurements (e.g. after a muscle
strength program), it is recommended to use the 3-repeti-
tion average strength measurement by one or more exam-
iners.
We performed intra- and inter-observer re-test measure-
ments on the same day. However, no learning effect was
found in the present study between the first and the third
strength measurement. This is probably due to the famil-
iarization session [21]. Although the highest value is
probably a more valid measurement for assessing muscle
strength [59] (even though it is less reliable), the average
of three MVPT strength measurements can be used in
determining whether a result is a real change or is within
the range of measurement error.
The protocol used for assessing isometric knee strength in
this study had acceptable re-test reliability, as evidenced
by ICCs equal to or greater than 0.75. The ICCs in the cur-
rent study are similar to test-retest reliability coefficients
reported in other, related studies [16,19,25-31].
The measurement error of HHD for knee extension
strength in haematological patients can be compared to
that observed in other studies. In a study in orthopaedic
knee patients, the intra-observer assessment of the SDD
was 21.5 Nm for the single value, and 13.8 Nm for the
average value. For inter-observer assessment, the SDD was
28.2 Nm for the single value and 18.7 Nm for the average
value [33]. However, one should keep in mind that the
authors used the 'make' method to assess knee extension
strength.
To compare our absolute reliability results for knee exten-
sion strength with those observed in COPD patients [16],
we estimated the SEM from their results. The SEM was
estimated from the ICC and the total variance, using the
formula SEM = Sd × (√1-ICC) [48]. A SDD (= SEM × 1.96
× √2) of approximately 49 Nm from knee extension was
calculated from their study results (ICC .87, Sd 14.5 Nm,
Table 2: Relative and absolute reliability of the average of 3 MVPT measurements
Intraclass correlation coefficient model ICC
(± 95%CI)
SEM (SEM as % of grand mean) SDD (SDD as % of grand mean)
Intra observer
ICC model 3.3
0.94
(0.86 – 0.97)
6.22 (3.98%) 17.23 (11.04%)
Inter observer
ICC model 2.3
0.89
(0.75 – 0.95)
9.65 (6.05%) 26.76 (16.77%)
The Intraclass correlation coefficient (ICC), the standard error of measurement (SEM), the smallest detectable difference (SDD) and the % of the 
grand mean for the intra- and inter-observer average MVPT value of knee extension strength measurements in patients with haematological 
malignancies are presented.
Table 3: Relative and absolute reliability of the highest value of 3 MVPT measurements
Intraclass correlation coefficient model ICC
(± 95%CI)
SEM (SEM as % of grand mean) SDD (SDD as % of grand mean)
Intra observer
ICC model 3.1
0.86
(0.71 – 0.94)
9.83 (5.88%) 27.26 (17.09%)
Inter observer
ICC model 2.1
0.77
(0.54 – 0.90)
11.41 (6.73%) 31.62 (18.66%)
The Intraclass correlation coefficient (ICC), the standard error of measurement (SEM), the smallest detectable difference (SDD) and the % of the 
grand mean for the intra- and inter-observer highest MVPT value of knee extension strength measurements in patients with haematological 
malignancies are presented.Page 6 of 11
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and corrected to an average lever arm of 34 cm, which was
the average 80% shank length of the included and
excluded participants in our study, (see table 2) [16]. An
important difference from our measurement protocol was
that the measurements in this study were performed with
a knee angle in 90 degrees of flexion.
From the study of Taylor et al. [31] among patients with
cerebral palsy, we were able to calculate a SDD of approx-
imately 43 Nm (ICC .81, Sd 10.7, strength value originally
expressed in Kg, converted to N and corrected to an aver-
age lever arm of 34 cm for Nm).
Excellent SEMs in knee arthroplasty patients were
described by Gagnon et al. The average SEM from 3 trials
was 1.84 Nm (SDD 5.10 Nm) [34]. However, in this latter
study, a chair-fixed device was used, and therefore was not
fully comparable with the results of hand held dynamom-
etry. In contrast to chair fixed dynamometry, the reliabil-
ity of strength measurements in HHD is influenced by the
experience of the examiners, the amount of strength that
examiners are able to resist, and the standardization of
measurements [33].
Currently, there is no criterion for the SDD of hand held
dynamometry. Therefore, the SDD in knee extension
strength was compared to studies that obtained quadri-
ceps strength measures after a resistive strength exercise
program. A relatively small improvement of 18 Nm
(95%CI 7–30 Nm, GM 144, Sd 45 Nm) was found in
patients with COPD [60]. Conversely, we estimated a
mean change of 29.92 Nm (CI95% 24 Nm to 35 Nm)
from the results of a study of breast cancer patients [12].
Although muscle strength in this study was assessed with
an eight repetition maximum, which is not fully compara-
ble to HHD, the findings indicated that cancer patients
may benefit from muscle strength training during chemo-
therapy treatment. Taken together, if obtained by the
same observer, the SDD threshold of 17 Nm (see table 2)
that corresponds to the average of 3 MVPT strength meas-
urements, will probably be surpassed.
For the average inter-examiner MVPT measurements with
the HHD, it is questionable if the threshold of 26 Nm (see
table 2) will be surpassed in all haematological patients
after a strength resistive training program. However, this is
probably the case only in patients who recover steadily
from the side effects of the medical treatment, and who
are good responders to resistive strength training.
Several limitations of the current study should be men-
tioned. First, the resultant moment at the knee joint and
the moment by the dynamometer are different. When
measuring isometric strength, one should keep in mind
that the differences between the measured and the result-
ant joint moments might influence the estimation of mus-
cle torque parameters. Although the test protocol can be
standardized to a reasonable degree, the deformation at
the soft tissue of the leg, especially at the thigh, where the
muscle mass is considerable, plays an important role in
changing the alignment of the HHD axis of rotation, and
the axis of the knee joint [61]. Therefore, future studies
need to examine the 'real' joint angles of hand-held
dynamometry measurements.
Second, the measurements in this study were performed
by female examiners without prior experience in muscle
strength assessment with HHD. This may have influenced
the upper boundary of the muscle strength assessments.
Knee extension strength measurements performed by
stronger examiners with experience in hand-held
dynamometry may result in measurement values that are
higher than 218 Nm. Moreover, the use of an isokinetic
Table 4: Average MVPT values for intra-observer 
measurements
Examination Grand mean (sd) Stand. error. mean p-value
Intra-Observer 1 155.5 (25) 5.1 0.508
Intra-Observer 2 157.1 (29.1) 5.9
Mean (sd), and standard error of the mean for the average value of 3 
MVPT intra-observer strength measurements.
Table 5: Average MVPT values for inter-observer 
measurements
Examination Grand mean (sd) Stand. error. mean p-value
Inter-Observer 1 165.6 (26.9) 5.4 0.340
Inter-Observer 2 168.5 (30.0) 6.1
Mean (sd), and standard error of the mean for the average value of 3 
MVPT inter-observer strength measurements.
Table 6: Highest MVPT values for intra-observer measurements
Examination Grand Mean (sd) Stand. Error. mean p-value
Intra-Observer 1 157.1 (29.1) 5.9 0.310
Intra-Observer 2 160.4 (23) 4.7
Mean (sd), and standard error of the mean for the highest value for 3 
MVPT intra-observer strength measurements.
Table 7: Highest MVPT values for inter-observer measurements
Examination Grand Mean (sd) Stand. Error. mean p-value
Inter-Observer 1 168.5 (30) 6.1 0.619
Inter-Observer 2 170.4 (23.8) 4.9
Mean (sd), and standard error of the mean for the highest value for 3 
MVPT inter-observer strength measurements.Page 7 of 11
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Distribution from Bland and Altman; average of 3 MVPT val-ue  for intra-observer measure e tsFigure 2
Distribution from Bland and Altman; average of 3 
MVPT values for intra-observer measurements. Eight 
data points are outside the ± 1.96 standard deviation bound-
aries. The ± 1.96 standard deviation boundaries represent 
approximately 15.19 Nm below and 11.25 Nm above the 
mean, which is -1.97 Nm.
Distribution from Bland and Altman; average of 3 MVPT val-ue  for inter-observer measure e tsFigure 3
Distribution from Bland and Altman; average of 3 
MVPT values for inter-observer measurements. Five 
data points are outside the ± 1.96 standard deviation bound-
aries. The ± 1.96 standard deviation boundaries represent 
approximately 21.29 Nm below and 11.51 Nm above the 
mean, which is -4.89 Nm.
Distribution from Bland and Altman; single MVPT values for intra-observe  measurementsFigure 4
Distribution from Bland and Altman; single MVPT 
values for intra-observer measurements. Six data 
points are outside the ± 1.96 standard deviation boundaries. 
The ± 1.96 standard deviation boundaries represent approxi-
mately 17.77 Nm below and 11.87 Nm above the mean, 
which is -2.95 Nm.
Distribution from Bland and Altman; single MVPT values for inter-observe  easurementsFigure 5
Distribution from Bland and Altman; single MVPT 
values for inter-observer measurements. Five data 
points are outside the ± 1.96 standard deviation boundaries. 
The ± 1.96 standard deviation boundaries represent approxi-
mately 20.36 Nm below and 16.56 Nm above the mean, 
which is -1.9 Nm.
BMC Musculoskeletal Disorders 2009, 10:31 http://www.biomedcentral.com/1471-2474/10/31dynamometer has been recommended if the muscle
strength of the patients exceeds the strength of the exam-
iners [21]. In several studies, isokinetic dynamometers
yielded reproducible measurements with low measure-
ment error [21,61-63]. However, isokinetic dynamome-
ters also have several disadvantages. They require a good
deal of space, and are costly, hampering their widespread
use in clinical settings. The reliability of a HHD measure-
ment may depend on the strength and the body mass of
the examiner. The female examiners in this study were of
varying weight. Examiner 2 achieved the highest (mean)
MVPT measurements.
Third, the point in time at which the assessments took
place varied considerably (see Table 1), and therefore
some patients may have had the possibility to recover
more from the side-effects of high-dose chemotherapy
than others. This may have influenced the inter-subject
variability, which in turn increases relative reliability
(ICCs). However, this inter-subject variability does not
effect absolute reliability (SEM, SDD). It is also possible
that the patients in our study were healthier than other
haematological cancer patients at the same stage of recov-
ery. The primary reason that 12 patients did not partici-
pate was that they felt too fatigued or too weak to do so.
Fourth: although we could not detect a learning effect
between the MVPT measurements, one should keep in
mind that the results of this reliability study are based on
an intra-day reliability assessment. A more complete pic-
ture of the reliability would require a between-day relia-
bility study to allow the corresponding variations to affect
(or not) the measures. Learning effects for strength meas-
urements can potentially be of more concern for between-
day than for within-day measurements [64,65]. In addi-
tion, if truly maximal exertions of muscle strength are
desired, visual feedback should be employed during the
measurements [66]. A factor that may also influence the
reliability of strength measurements is the circadian
rhythm. A time-of-day effect for leg and back strength
measurements was reported in one study in which maxi-
mum strength values increased consistently during day-
time [67]. Gauthier et al. [68] reported similar findings for
elbow flexion torque and body temperature, which varied
concomitantly during the day. One should keep in mind
that circadian rhythm disruption is hypothesized as a
mechanism underlying fatigue in cancer patients [69].
Fatigue is one of the most prevalent symptoms that cancer
patients experience and it has a considerable effect on
physical performance [70]. Therefore, fatigue may also
influence the reliability of the measurements in cancer
patients.
Fifth, at the end-phase of the training period, the upper
limit for the examiners torque was fixed at 218 Nm,
because the weakest examiner was able to break through
the knee extension movement of the 3 pre-test patients at
218 Nm, but not higher. Thus, only haematological can-
cer patients with knee extension measurements lower
than this value were included in the analysis.
Finally, this study had a relatively small sample size.
Although the sample size was adequate for studies of this
nature [71], a larger study might narrow the confidence
intervals around the reliability coefficients (without nec-
essarily affecting the reliability estimates themselves).
Clinical implications for the use of a HHD in patients with 
haematological malignancies
In this reliability study both participating assessors were
students of the Institute of Human Movement Sciences
and Sport. They underwent training sessions to learn the
requisite manual muscle testing skills during 8 sessions of
1.5 hours each. The data for the average intra-examiner
MVPT measurements in 24 patients with hematological
malignancies yielded acceptable results for relative (ICC
0.94) and absolute reliability (SDD 17 Nm).
The conflicting finding on inter-examiner reliability,
where the experience of the assessing examiners seem-
ingly plays an important role, has important clinical
implications. If more than one examiner is to evaluate the
muscle strength of a haematological patient, then it is
important that all examiners concerned apply the tests
reliably and consistently. If this can not be achieved, then
the resulting data will be of little use in a clinical setting.
Clinicians specialized in the treatment of chronic diseases,
and with comparable levels of practical experience with
an HHD can, however, use the average MVPT value for
intra-examiner measurements in their everyday practice
with confidence. The HHD may be used in patients with
haematological malignancies who have recovered from
the direct side-effects of their medical treatment and who
are in a stable physical condition to: 1) compare muscle
strength with normative reference values (e.g. for discrim-
inative purpose); or 2) evaluate the effect of a resistive
exercise training in an individual patient (e.g. measure
change in health status over time).
Conclusion
The results of this study indicate that there is acceptable
relative reliability for evaluating knee strength with an
HHD, while the observed measurement error is modest.
The HHD may be useful in detecting changes in knee
extension strength at the individual patient level.
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